Live feed08:35:32·9mANALYSTRatingvia QuantisnowH.C. Wainwright resumed coverage on Verrica Pharmaceuticals with a new price targetByQuantisnow·Wall Street's wire, on your screen.VRCA· Verrica Pharmaceuticals Inc.Health CareOriginal source